United Therapeutics Corporation
Symbol: UTHR
NASDAQ
258.13
USDDzisiejsza cena rynkowa
11.5489
Wskaźnik P/E
-0.0982
Wskaźnik PEG
11.45B
Kapitalizacja MRK
- 0.00%
Rentowność DIV
United Therapeutics Corporation (UTHR) Sprawozdania finansowe
Bilans
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 13884.5 | 2994.1 | 4154.9 | 3580.6 | ||||||||||||||||||||||||||
balance-sheet.row.short-term-investments | 9250.3 | 1786.4 | 1877.5 | 1035.9 | ||||||||||||||||||||||||||
balance-sheet.row.net-receivables | 1117.5 | 278.9 | 220.4 | 198.7 | ||||||||||||||||||||||||||
balance-sheet.row.inventory | 439.6 | 111.8 | 102 | 93.8 | ||||||||||||||||||||||||||
balance-sheet.row.other-current-assets | 5494.3 | 166.2 | 219.2 | 100.4 | ||||||||||||||||||||||||||
balance-sheet.row.total-current-assets | 13472 | 3551 | 3380.3 | 2323.6 | ||||||||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 4050.5 | 1045.4 | 861.5 | 780.9 | ||||||||||||||||||||||||||
balance-sheet.row.goodwill | 33.7 | 33.7 | 28 | 28 | ||||||||||||||||||||||||||
balance-sheet.row.intangible-assets | 169.4 | 80.5 | 16.5 | 16.6 | ||||||||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 318.5 | 114.2 | 44.5 | 44.6 | ||||||||||||||||||||||||||
balance-sheet.row.long-term-investments | 7486.1 | 1909.8 | 1316.2 | 1649.9 | ||||||||||||||||||||||||||
balance-sheet.row.tax-assets | 1442.1 | 394.8 | 327.7 | 261.9 | ||||||||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 597.9 | 151.8 | 114.3 | 108.2 | ||||||||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 13895.1 | 3616 | 2664.2 | 2845.5 | ||||||||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||
balance-sheet.row.total-assets | 27367.1 | 7167 | 6044.5 | 5169.1 | ||||||||||||||||||||||||||
balance-sheet.row.account-payables | 631 | 5.6 | 4.1 | 3.8 | ||||||||||||||||||||||||||
balance-sheet.row.short-term-debt | 700 | 400 | 0 | 0 | ||||||||||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 1800 | 300 | 800 | 800 | ||||||||||||||||||||||||||
Deferred Revenue Non Current | -42.4 | -42.4 | -41 | -30 | ||||||||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 42.4 | - | - | - | ||||||||||||||||||||||||||
balance-sheet.row.other-current-liab | 1454 | 71 | 339.1 | 301.6 | ||||||||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 2141.7 | 377.8 | 904.6 | 904.8 | ||||||||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 32.8 | 32.8 | 0 | 0 | ||||||||||||||||||||||||||
balance-sheet.row.total-liab | 4921.1 | 1182.2 | 1247.8 | 1210.2 | ||||||||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||
balance-sheet.row.common-stock | 2.8 | 0.7 | 0.7 | 0.7 | ||||||||||||||||||||||||||
balance-sheet.row.retained-earnings | 23713.2 | 6027.1 | 5042.3 | 4315 | ||||||||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | -122.7 | -12.8 | -55.5 | -23 | ||||||||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | -1147.3 | -30.2 | -190.8 | -333.8 | ||||||||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 22446 | 5984.8 | 4796.7 | 3958.9 | ||||||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 27367.1 | 7167 | 6044.5 | 5169.1 | ||||||||||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||
balance-sheet.row.total-equity | 22446 | 5984.8 | 4796.7 | 3958.9 | ||||||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 27367.1 | - | - | - | ||||||||||||||||||||||||||
Total Investments | 9272.5 | 3696.2 | 3193.7 | 2685.8 | ||||||||||||||||||||||||||
balance-sheet.row.total-debt | 2200 | 700 | 800 | 800 | ||||||||||||||||||||||||||
balance-sheet.row.net-debt | -2434.2 | -507.7 | -161.2 | -94.8 |
Rachunek przepływów pieniężnych
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 1050.5 | 984.8 | 727.3 | 475.8 | ||||||||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 54.9 | 53.2 | 51.3 | 49.9 | ||||||||||||||||||||||||||
cash-flows.row.deferred-income-tax | 71 | 3.6 | -71.7 | -89.7 | ||||||||||||||||||||||||||
cash-flows.row.stock-based-compensation | 51.5 | 39.1 | 106.8 | 138.5 | ||||||||||||||||||||||||||
cash-flows.row.change-in-working-capital | -219.9 | -97.8 | -35.1 | -48.8 | ||||||||||||||||||||||||||
cash-flows.row.account-receivables | -172.7 | -58.5 | -21.7 | -41.3 | ||||||||||||||||||||||||||
cash-flows.row.inventory | -20.4 | -13.6 | -13.4 | -7.5 | ||||||||||||||||||||||||||
cash-flows.row.account-payables | 61.3 | 57.1 | 150.6 | 112.9 | ||||||||||||||||||||||||||
cash-flows.row.other-working-capital | -123.8 | -82.8 | -150.6 | -112.9 | ||||||||||||||||||||||||||
cash-flows.row.other-non-cash-items | -313.1 | -4.9 | 23.9 | 72.5 | ||||||||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 979.7 | 0 | 0 | 0 | ||||||||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -227.3 | -230.4 | -138.8 | -120.8 | ||||||||||||||||||||||||||
cash-flows.row.acquisitions-net | 326.7 | -89.2 | 7.1 | 366.1 | ||||||||||||||||||||||||||
cash-flows.row.purchases-of-investments | -2154.1 | -2514.3 | -1708.6 | -1895.3 | ||||||||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 1902.9 | 2137.3 | 1025.3 | 1529.2 | ||||||||||||||||||||||||||
cash-flows.row.other-investing-activites | 388.6 | -23 | 3.5 | -366.1 | ||||||||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 236.8 | -719.6 | -811.5 | -486.9 | ||||||||||||||||||||||||||
cash-flows.row.debt-repayment | -100 | -100 | -800 | 0 | ||||||||||||||||||||||||||
cash-flows.row.common-stock-issued | 43.7 | 6.6 | 94.3 | 55.6 | ||||||||||||||||||||||||||
cash-flows.row.common-stock-repurchased | -1000.3 | -13.8 | -11.4 | -10.8 | ||||||||||||||||||||||||||
cash-flows.row.dividends-paid | 0 | -98 | -94.3 | 0 | ||||||||||||||||||||||||||
cash-flows.row.other-financing-activites | -40.1 | 193.3 | 886.8 | -10.8 | ||||||||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -1128.5 | -11.9 | 75.4 | 44.8 | ||||||||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||
cash-flows.row.net-change-in-cash | 88 | 246.5 | 66.4 | 156.1 | ||||||||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 4634.2 | 1207.7 | 961.2 | 894.8 | ||||||||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 4546.2 | 961.2 | 894.8 | 738.7 | ||||||||||||||||||||||||||
cash-flows.row.operating-cash-flow | 979.7 | 978 | 802.5 | 598.2 | ||||||||||||||||||||||||||
cash-flows.row.capital-expenditure | -227.3 | -230.4 | -138.8 | -120.8 | ||||||||||||||||||||||||||
cash-flows.row.free-cash-flow | 752.4 | 747.6 | 663.7 | 477.4 |
Wiersz rachunku zysków i strat
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 2498.3 | 2327.5 | 1936.3 | 1685.5 | ||||||||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 278.1 | 257.5 | 146.7 | 122.5 | ||||||||||||||||||||||||||
income-statement-row.row.gross-profit | 2220.2 | 2070 | 1789.6 | 1563 | ||||||||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||
income-statement-row.row.research-development | 429.2 | - | - | - | ||||||||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 324.9 | - | - | - | ||||||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 64.9 | - | - | - | ||||||||||||||||||||||||||
income-statement-row.row.other-expenses | -6.1 | -14 | -40.2 | 42.2 | ||||||||||||||||||||||||||
income-statement-row.row.operating-expenses | 961.6 | 885.1 | 809.9 | 1007.1 | ||||||||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 1239.7 | 1142.6 | 956.6 | 1129.6 | ||||||||||||||||||||||||||
income-statement-row.row.interest-income | 187.3 | 162.7 | 45.2 | 16.7 | ||||||||||||||||||||||||||
income-statement-row.row.interest-expense | 32.2 | 59.3 | 32.4 | 18.6 | ||||||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 64.9 | - | - | - | ||||||||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 36.2 | -14 | -29.1 | 38 | ||||||||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||||||||||||
income-statement-row.row.other-operating-expenses | -6.1 | -14 | -40.2 | 42.2 | ||||||||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 36.2 | -14 | -29.1 | 38 | ||||||||||||||||||||||||||
income-statement-row.row.interest-expense | 32.2 | 59.3 | 32.4 | 18.6 | ||||||||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 104 | 53.2 | 5 | 58.9 | ||||||||||||||||||||||||||
income-statement-row.row.ebitda-caps | 1411.2 | - | - | - | ||||||||||||||||||||||||||
income-statement-row.row.operating-income | 1256.8 | 1184.9 | 979.7 | 555.9 | ||||||||||||||||||||||||||
income-statement-row.row.income-before-tax | 1381 | 1274.3 | 950.6 | 593.9 | ||||||||||||||||||||||||||
income-statement-row.row.income-tax-expense | 330.5 | 289.5 | 223.3 | 118.1 | ||||||||||||||||||||||||||
income-statement-row.row.net-income | 1050.5 | 984.8 | 727.3 | 475.8 |
Często zadawane pytania
Ile wynosi United Therapeutics Corporation (UTHR) aktywów ogółem?
United Therapeutics Corporation (UTHR) całkowite aktywa to 7167000000.000.
Jaki jest roczny przychód przedsiębiorstwa?
Roczny przychód to 1292400000.000.
Jaka jest marża zysku firmy?
Marża zysku firmy to 0.889.
Czym są wolne przepływy pieniężne firmy?
Wolne przepływy pieniężne to 16.009.
Jaka jest marża zysku netto przedsiębiorstwa?
Marża zysku netto to 0.420.
Jaki jest całkowity przychód firmy?
Całkowity przychód to 0.503.
Co to jest United Therapeutics Corporation (UTHR) zysk netto (dochód netto)?
Zysk netto (dochód netto) wynosi 984800000.000.
Jakie jest całkowite zadłużenie firmy?
Całkowite zadłużenie to 700000000.000.
Ile wynoszą koszty operacyjne?
Wydatki operacyjne to 885100000.000.
Jaka jest wartość gotówki firmy?
Środki pieniężne przedsiębiorstwa to 1251500000.000.